Product Information

SIMVASTATIN 40 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $0.0543 per EA under NDC 70377000412. Its NADAC has been published 415 times since Sep 12, 2018.

FDA first approved this application on Dec 20, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SIMVASTATIN 40 MG TABLET

Simvastatin
$0.0543per EA

Strength

40 mg/1

Manufacturer

Biocon Pharma Inc.

NDC

70377000412

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

SIMVASTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA078034

FDA Approved

12/20/2006

TE Code

AB

On Market Since

12/17/2015

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for SIMVASTATIN 40 MG TABLET has been published 415 times since Sep 12, 2018, and over the history we have for it it has risen 62.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0543 per EA
All-time high$0.0701 (Nov 15, 2023)
All-time low$0.0334 (Sep 12, 2018)
52-week high$0.0547
52-week low$0.0519
Median price$0.0443
Average price$0.0481
Largest weekly change+29.8% (Aug 21, 2024)
Weeks tracked415
Tracking sinceSep 12, 2018

Price History

1W

+0.8%

1M

+0.8%

3M

+0.7%

6M

-0.7%

1Y

+1.2%

3Y

+0.0%

5Y

+16.5%

All

+62.3%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SIMVASTATIN 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 40 MG TABLET, manufactured by Biocon Pharma Inc., is $0.0543 per EA (NDC 70377000412), effective Aug 19, 2026.

How has the price of SIMVASTATIN 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for SIMVASTATIN 40 MG TABLET has risen 62.3%. It has been tracked across 415 weekly CMS publications since Sep 12, 2018.

What are the highest and lowest recorded NADAC prices for SIMVASTATIN 40 MG TABLET?

Since Sep 12, 2018, the NADAC for SIMVASTATIN 40 MG TABLET has ranged from a low of $0.0334 (Sep 12, 2018) to a high of $0.0701 (Nov 15, 2023), with a median of $0.0443 per EA.

Are there cheaper alternatives to SIMVASTATIN 40 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 40 MG TABLET, is $0.0410 per EA — about 24% below SIMVASTATIN 40 MG TABLET.

Who manufactures SIMVASTATIN 40 MG TABLET?

SIMVASTATIN 40 MG TABLET (NDC 70377000412) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.